| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/DMRR.1288 |
| P698 | PubMed publication ID | 22218757 |
| P2093 | author name string | Bruno Vergès | |
| Véronique Kerlan | |||
| Jean Marcel Brun | |||
| Camille Tawil | |||
| Bertrand Alexandre | |||
| P2860 | cites work | Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes | Q24642503 |
| Randomized, controlled trials, observational studies, and the hierarchy of research designs | Q24670544 | ||
| Importance of observational studies in clinical practice. | Q30366090 | ||
| Fear of hypoglycemia: quantification, validation, and utilization | Q30463252 | ||
| Transition from specialist to primary diabetes care: a qualitative study of perspectives of primary care physicians | Q33461936 | ||
| Combination therapies with insulin in type 2 diabetes | Q34227542 | ||
| Treating to goal: challenges of current management | Q35919897 | ||
| A randomised, 52-week, treat-to-target trial comparing insulin detemir with insulin glargine when administered as add-on to glucose-lowering drugs in insulin-naive people with type 2 diabetes | Q36449523 | ||
| Overcoming psychological barriers to insulin use in type 2 diabetes | Q36580989 | ||
| Frequency and risk factors of severe hypoglycemia in insulin-treated type 2 diabetes: a literature survey. | Q36637028 | ||
| Towards peakless, reproducible and long-acting insulins. An assessment of the basal analogues based on isoglycaemic clamp studies | Q36889115 | ||
| Insulin-associated weight gain in diabetes--causes, effects and coping strategies | Q36966075 | ||
| Lifestyle approach for type 2 diabetes and metabolic syndrome. | Q37304363 | ||
| Comparison of once-daily insulin detemir with NPH insulin added to a regimen of oral antidiabetic drugs in poorly controlled type 2 diabetes | Q42605636 | ||
| A 52-week, multinational, open-label, parallel-group, noninferiority, treat-to-target trial comparing insulin detemir with insulin glargine in a basal-bolus regimen with mealtime insulin aspart in patients with type 2 diabetes | Q42607495 | ||
| Insulin detemir improves glycaemic control without weight gain in insulin-naïve patients with type 2 diabetes: subgroup analysis from the PREDICTIVE study | Q42647603 | ||
| Clinical inertia in response to inadequate glycemic control: do specialists differ from primary care physicians? | Q45285707 | ||
| Comparison of insulin detemir and insulin glargine in subjects with Type 1 diabetes using intensive insulin therapy | Q46707992 | ||
| Epidemiology and correlates of weight worry in the multinational Diabetes Attitudes, Wishes and Needs study | Q47178820 | ||
| Psychosocial problems and barriers to improved diabetes management: results of the Cross-National Diabetes Attitudes, Wishes and Needs (DAWN) Study | Q47249345 | ||
| Insulin detemir results in less weight gain than NPH insulin when used in basal-bolus therapy for type 2 diabetes mellitus, and this advantage increases with baseline body mass index | Q47297341 | ||
| Adherence to insulin and its association with glycaemic control in patients with type 2 diabetes. | Q51101840 | ||
| Pain following controlled cutaneous insertion of needles with different diameters. | Q51162680 | ||
| Management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: update regarding thiazolidinediones: a consensus statement from the American Diabetes Association and the European Association for th | Q51897454 | ||
| Randomized trials or observational tribulations? | Q73911098 | ||
| When oral agents fail: practical barriers to starting insulin | Q74601463 | ||
| P433 | issue | 1 | |
| P921 | main subject | preproinsulin | Q7240673 |
| P304 | page(s) | 97-105 | |
| P577 | publication date | 2012-01-01 | |
| P1433 | published in | Diabetes - Metabolism: Research and Reviews | Q15750056 |
| P1476 | title | Strategies for insulin initiation: insights from the French LIGHT observational study. | |
| P478 | volume | 28 |
| Q42656363 | A review of current models for initiating injectable therapy for people with type 2 diabetes in primary care |
| Q38107347 | Combination therapy with DPP-4 inhibitors and insulin in patients with type 2 diabetes mellitus: what is the evidence? |
| Q27009355 | Common standards of basal insulin titration in type 2 diabetes |
| Q38176344 | Comparing dosing of basal insulin analogues detemir and glargine: is it really unit-per-unit and dose-per-dose? |
| Q26784192 | Drug-related risk of severe hypoglycaemia in observational studies: a systematic review and meta-analysis |
| Q37577129 | How do we continue treatment in patients with type 2 diabetes when therapeutic goals are not reached with oral antidiabetes agents and lifestyle? Incretin versus insulin treatment |
| Q31046934 | Hypoglycemia Event Rates: A Comparison Between Real-World Data and Randomized Controlled Trial Populations in Insulin-Treated Diabetes |
| Q36924493 | Impact of telephonic interviews on persistence and daily adherence to insulin treatment in insulin-naïve type 2 diabetes patients: dropout study |
Search more.